Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Aassi · SciRah

Researcher profile · Semantic Scholar

M. Aassi

Share profile

M. Aassi — researcher profile on SciRah

h-index: 9
Works: 21
Citations: 442

Most-cited papers

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
T. Huizinga, P. Conaghan, E. Martı́n-Mola, G. Schett +6 more
2013Annals of the Rheumatic Diseases114 citations Open access
Semantic Scholar
Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review
J. Curtis, V. Bykerk, M. Aassi, M. Schiff
2016Journal of Rheumatology94 citations Open access
Semantic Scholar
Treatment of Rheumatoid Arthritis With Anti–Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study
E. Choy, C. Bernasconi, M. Aassi, J. Molina +1 more
2017Arthritis care & research47 citations Open access
Semantic Scholar
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
V. Bykerk, A. Östör, J. Álvaro-Gracia, K. Pavelka +8 more
2015Clinical Rheumatology39 citations Open access
Semantic Scholar
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
J. Merola, I. McInnes, A. Deodhar, A. Dey +5 more
2022Rheumatology and Therapy37 citations Open access
Semantic Scholar
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
U. Kiltz, P. Sfikakis, K. Gaffney, P. Sator +18 more
2020Advances in Therapy36 citations Open access
Semantic Scholar
Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study
M. Augustin, P. Sator, R. von Kiedrowski, C. Conrad +8 more
2022Journal of the European Academy of Dermatology and Venereology27 citations Open access
Semantic Scholar
First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
M. Kaul, Philip Jarvis, I. Rozenberg, Frank Kolbinger +9 more
2020Journal of the European Academy of Dermatology and Venereology23 citations Open access
Semantic Scholar
Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial
M. Dougados, T. Huizinga, E. Choy, C. Bingham +2 more
2015Arthritis care & research12 citations Open access
Semantic Scholar
Twelve‐week secukinumab treatment is consistently efficacious for moderate‐to‐severe psoriasis regardless of prior biologic and non‐biologic systemic treatment: Post hoc analysis of six randomised trials
P. Hampton, A. Halliday, M. Aassi, Subhashini Subramanian +2 more
2020Journal of the European Academy of Dermatology and Venereology5 citations Open access
Semantic Scholar
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis
K. Reich, X. Baraliakos, L. Coates, B. Elewski +7 more
2022British Journal of Dermatology3 citations
Semantic Scholar
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls
T. Eviatar, V. Furer, A. Polachek, D. Zisman +13 more
2023Journal of Rheumatology2 citations
Semantic Scholar
P79 Real-world outcomes of disease-modifying treatment for patients with spinal muscular atrophy: findings from a global retrospective chart review
O. Dabbous, N. LaMarca, W. Toro, S. Wallach +5 more
2023Neuromuscular Disorders1 citations
Semantic Scholar
POS1244 THE EFFECT OF SECUKINUMAB ON THE HUMORAL RESPONSE FOLLOWING TWO AND THREE DOSES OF THE BNT162b2 mRNA VACCINE IN PATIENTS WITH SPONDYLOARTHRITIS
O. Elkayam, T. Eviatar, H. Peleg, D. Paran +16 more
2022Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
25851 Efficacy of secukinumab in managing axial manifestations and nail psoriasis in patients with psoriatic arthritis: Results from the MAXIMISE trial
A. Gottlieb, X. Baraliakos, L. Coates, E. Pournara +6 more
20211 citations
Semantic Scholar
096 Treatment of Rheumatoid Arthritis with an Anti-Tumour Necrosis Factor Agent or Tocilizumab as First Biologic Therapy: Act-Ion, A Global Comparative Observational Study
E. Choy, C. Bernasconi, M. Aassi, J. Molina +1 more
20161 citations Open access
Semantic Scholar
25385 Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analyses from phase III studies in psoriasis and psoriatic arthritis (PsA)
K. Reich, X. Baraliakos, L. Coates, A. Gottlieb +7 more
20210 citations
Semantic Scholar
17570 Secukinumab demonstrated high efficacy in clearing nail psoriasis: Results from posthoc analyses from the phase III programs
K. Reich, P. Nash, B. Kirkham, W. Bao +4 more
2020Journal of American Academy of Dermatology0 citations Open access
Semantic Scholar
Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
V. Bykerk, A. Östör, J. Álvaro-Gracia, K. Pavelka +8 more
2015Clinical Rheumatology0 citations Open access
Semantic Scholar
AB0500 Development of a New Methotrexate-Specific Adherence Tool for use in the Management of Patients with Rheumatoid Arthritis
M. Aassi, C. Barbosa, C. Bernasconi, M. Brethous +2 more
20150 citations
Semantic Scholar
SAT0255 Clinical and Radiographic Outcomes at 2 Years and the Effect of TOCILIZUMAB Discontinuation following Sustained Remission in the Second and Third Year of the ACT-RAY Study
T. Huizinga, P. Conaghan, E. Martı́n-Mola, G. Schett +6 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Bernasconi×8
Invite
C. Bernasconi — researcher profile on SciRah
C. Perella×4
Invite
C. Perella — researcher profile on SciRah
E. Pournara×4
Invite
E. Pournara — researcher profile on SciRah
K. Reich×4
Invite
K. Reich — researcher profile on SciRah

×3

Invite

M. Dougados — researcher profile on SciRah

Invite

V. Bykerk — researcher profile on SciRah

Invite

E. Choy — researcher profile on SciRah

E. Quebe‐Fehling×3

Invite

E. Quebe‐Fehling — researcher profile on SciRah

Invite

L. Coates — researcher profile on SciRah

Invite

B. Elewski — researcher profile on SciRah

Invite

W. Bao — researcher profile on SciRah

Invite

C. Gaillez — researcher profile on SciRah